Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1997-09-15
2000-01-25
Dees, Jose' G.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
424 111, 424 165, 530300, 530329, 534 10, 534 14, A61K 5100, A61M 3614
Patent
active
060175125
ABSTRACT:
This invention relates to therapeutic reagents and peptides, including radiotherapeutic reagents and peptides, radiodiagnostic reagents and peptides, and methods for producing labeled radiodiagnostic agents. Specifically, the invention relates to cyclic peptide derivatives and analogs of somatostatin, and embodiments of such peptides radiolabeled with a radioisotope, as well as methods and kits for making, radiolabeling and using such peptides for radiodiagnostic and radiotherapeutic purposes. The invention specifically relates to cyclic peptide derivatives and analogues of somatostatin radiolabeled with technetium-99m and uses thereof as scintigraphic imaging agents. The invention also specifically relates to cyclic peptide derivatives and analogues of somatostatin radiolabeled with cytotoxic radioisotopes such as rhenium-186 (.sup.186 Re) and rhenium-188 (.sup.188 Re) for use as radiotherapeutic agents. Methods and kits for making, radiolabeling and using such peptides diagnostically and therapeutically in a mammalian body are also provided.
REFERENCES:
patent: 4191754 (1980-03-01), Vaber et al.
patent: 4224199 (1980-09-01), Meyers et al.
patent: 4310518 (1982-01-01), Freidinger et al.
patent: 4358439 (1982-11-01), Sieber et al.
patent: 4444690 (1984-04-01), Fritzberg et al.
patent: 4472509 (1984-09-01), Gansow et al.
patent: 4485101 (1984-11-01), Coy et al.
patent: 4571430 (1986-02-01), Byrne et al.
patent: 4585755 (1986-04-01), Morgan et al.
patent: 4608251 (1986-08-01), Mia
patent: 4611054 (1986-09-01), Freidinger
patent: 4612366 (1986-09-01), Nutt
patent: 4650787 (1987-03-01), Schally et al.
patent: 4725577 (1988-02-01), Schally et al.
patent: 4853371 (1989-08-01), Coy et al.
patent: 4871717 (1989-10-01), Coy et al.
patent: 4904642 (1990-02-01), Coy et al.
patent: 4986979 (1991-01-01), Morgan, Jr. et al.
patent: 5073541 (1991-12-01), Taylor et al.
patent: 5084442 (1992-01-01), Felix et al.
patent: 5095111 (1992-03-01), Lever et al.
patent: 5196510 (1993-03-01), Rodwell
patent: 5212072 (1993-05-01), Blalock et al.
patent: 5225180 (1993-07-01), Dean et al.
patent: 5382654 (1995-01-01), Lyle et al.
patent: 5405597 (1995-04-01), Dean et al.
patent: 5443815 (1995-08-01), Dean et al.
patent: 5443816 (1995-08-01), Zamora et al.
patent: 5508020 (1996-04-01), Dean et al.
patent: 5556939 (1996-09-01), Flanagan et al.
patent: 5716596 (1998-02-01), Dean et al.
Rhodes, 1974, Sem. Nucl. Med. 4: 281-293.
Khaw et al., 1982, J. Nucl. Med. 23: 1011-1019.
Byrne & Tolman, 1983, J. Nucl. Med. 24: 126 (1983).
Bakker et al., J. Nucl. Med. 32: 1184-1189 (1991).
Kwekkeboom et al., 1991, J. Nucl. Med. 32: 981 Abstract #305.
Bomanji et al., 1992, "A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors", J. Nucl. Med. 33: 1121-1124.
Krenning et al., 1992, "Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: Metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide", J. Nucl. Med. 33: 652-658.
Cox et al., 1991, "Technetium Labeled Somatostatin: A Potential Agent for In Vivo Tumour Localization", Abstract, 7th International Symposium on Radiopharmacology, p. 16.
Albert et al., 1991, "A Somatostatin Analogue to Image SS-Receptor-Positive Tumours: [111In-DTPA-DPhe]11-Octreotide (SDZ 215-811)", Abstract LM10, 12th American Peptide Symposium: 1991.
Faglia et al., 1991, "In vivo detection of somatostatin receptors in patients with functionless pituitary adenomas by means of a radiodinated analog of somatostatin ([123I]SDZ 204-090)", J. Clin. Endocrinol. Meta. 73:850-856.
Larson, 1991, "Receptors on Tumors Studied with Radionuclide Scintigraphy", J. Nucl. Med. 32: 1189-1191.
Kessler et al., (1989) "Dimerisation of cyclic hexapeptides: strong increase of biological activity.," Peptides 1988, pp. 664-666.
Bean et al., (1990) "Identification of a thioether byproduct in the synthesis of a cyclic disulfide peptide by tandem mass spectrometry," in Rivier et al., "Peptides: Chemistry, Structre and Biology," Escom, Leiden.
Li et al., (Oct. 1991)"A new bifunctional chelating agent alpha, epsilon-N, N-bis(L-cyteinyl)-L-lysine for radiolabeling of monoclonal antibodies with TC-99m," Chemical Abstracts, vol. 115, No. 15, abstract No. 159733.
Bryson, (1990) "Protecting Groups in the Preparation of Thiolate Complexes of Technitium.," Inorganic Chemistry 29(16), 2948-2951.
Aaron, (Sep. 1991) "A novel bifunctional metabolisable linker for the conjugation of antibodies with radionucleotides.," Bioconj. Chem. 2(2), 71-76.
Reubi et al., Chem. Abstracts, 103: 135620 (1985).
Brady et al., (Apr. 1993) "Approaches to peptidomimetics which serve as surrogates for the CIS amide bond: Novel Disulfide Constrained Bicyclis Hexapeptide Analogs . . . " Tetrahedron, vol. 49, No. 17, pp. 3449-3466.
Pearson et al., "Somatostatin Receptor Binding Peptides Labeled with Technetium-99m Chemistry and Initial Biological Studies." (1996), J. Med. Chem., vol. 39, No. 7. pp. 1361-1371.
Cotton et al., (1966) Inorg. Chem. 5: 9-16.
Lamberts, (1991) J. Nucl. Med. 32: 1189-1191.
Lebl et al., (1984) "Synthesis of cyclic peptides by solid phase methodology." Tetrahedron Letters. vol. 25, No. 20, pp. 2067-2068.
Jost et al., (Oct. 1974) "Synthesis and some biological activities of analogues of deamino-vasopressin with the disulphide bridge altered to a thioether bridge." Coll. of Czech. Chem. Comm., vol. 39, No. 10, pp.2835-2856.
Jung et al., (Jul. 1990) "Peptides with sulfide bridges and dehydroamino acids: their prepropeptides and possibilities for bioengineering." Proceeding of the XI American Peptide Symposium, pp. 865-869.
Palmer et al., (Jul. 1992) "Effects of dehydroalanine on peptide conformation." Journal of the American Chemical Society, vol. 114, No. 14, pp.5634-5642.
Dean Richard T.
Lister-James John
McBride William
Dees Jos,e G.
Diatide, Inc.
Jones Dameron
McDaniels Patricia A.
LandOfFree
Radiolabeled peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiolabeled peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabeled peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2313731